ADMA Biologics Taps Brad Tade as CFO

By MarketWatch | Jul 26, 2024 at 06:13 PM EST

Brad Tade has been named the new Chief Financial Officer of ADMA Biologics. He previously held the position of VP of financial operations. The annual salary is $435,000 with a bonus potential of 45%. This follows the transition of former CFO Brian Lenz to a consulting role.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.